Chris Prue
About Chris Prue
Christopher Prue at Rani Therapeutics
Christopher Prue joined the management team at Rani Therapeutics as Senior Director, Regulatory Affairs in July 2021. His role focuses on overseeing regulatory strategies to ensure compliance and successful submissions for the company's innovative therapies. Prue's extensive background in regulatory affairs brings valuable expertise to Rani Therapeutics' efforts in advancing their pharmaceutical developments.
Christopher Prue's Professional Experience
Christopher Prue has more than 40 years of experience in the pharmaceutical industry, with 38 years dedicated to Regulatory Affairs. His career spans roles in both regulatory and pharmacovigilance leadership at various Biotech and Pharma companies, including BioDelivery Sciences Inc., Purdue Pharma LP, Incara Pharmaceuticals, Glaxo Wellcome Inc., and The Upjohn Company. Prue's regulatory submissions experience covers INDs, NDAs, BLAs, and ANDAs in the US, as well as CTAs and MAAs in the EU, Canada, South America, and Asia.
Christopher Prue's Education Background
Christopher Prue holds a bachelor's degree in Pharmacy from Purdue University. He furthered his education by earning an MBA with a major concentration in marketing from Western Michigan University. This academic foundation has supported his extensive career in regulatory affairs and pharmaceutical leadership.
Christopher Prue's Regulatory Expertise
With 38 years of experience in Regulatory Affairs, Christopher Prue has developed diversified therapeutic area expertise. His proficiency in regulatory submissions includes INDs, NDAs, BLAs, and ANDAs in the US, and CTAs and MAAs internationally. Prue's regulatory knowledge and experience are essential assets for navigating the complex landscape of pharmaceutical regulations and ensuring successful product approvals.